A multi-omics landscape of programmed cell death in acetaminophen-induced acute kidney injury

Jianxin Zheng1, Peng Lai1, Jiaheng Wu2,3

  • 1Department of Urology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.

Renal Failure
|November 17, 2025
PubMed

Insights

Acetaminophen overdose causes kidney injury through multiple programmed cell death pathways. Inhibiting AKT protein kinase reduced injury by modulating cell death and survival signals, identifying AKT as a key target for nephrotoxicity.

Area of Science:

  • Nephrology and Toxicology
  • Molecular Biology and Cell Death Mechanisms

Background:

  • Acetaminophen (APAP) overdose is a significant cause of acute kidney injury (AKI).
  • The precise molecular pathways driving APAP-induced nephrotoxicity are not fully understood.
  • Programmed cell death (PCD) pathways are implicated but require comprehensive evaluation in APAP nephrotoxicity.

Purpose of the Study:

  • To comprehensively analyze the involvement of 13 distinct programmed cell death (PCD) pathways in early-stage APAP-induced nephrotoxicity.
  • To identify key molecular players and signaling hubs regulating APAP-induced kidney injury.
  • To explore potential therapeutic strategies targeting identified pathways, specifically focusing on protein kinase B (AKT) inhibition.

Main Methods:

  • Integrated transcriptomic, proteomic, and phosphoproteomic analyses of mouse kidney tissues.
  • Systematic evaluation of 884 genes across 13 programmed cell death (PCD) pathways.
  • In vivo inhibition of AKT and extracellular signal-regulated kinase (ERK) to assess therapeutic effects.

Main Results:

  • Multiple PCD pathways, including alkaliptosis, cuproptosis, disulfidptosis, lysosome-dependent cell death, netotic cell death, and pyroptosis, were activated by APAP.
  • Proteomic analysis confirmed enrichment in alkaliptosis, apoptosis, entotic cell death, ferroptosis, necroptosis, netotic cell death, oxeiptosis, and pyroptosis.
  • In vivo AKT inhibition significantly reduced kidney injury, improved histopathology, and suppressed ferroptosis markers, while enhancing survival signaling.

Conclusions:

  • Multiple programmed cell death (PCD) pathways are critically involved in early acetaminophen-induced nephrotoxicity.
  • Protein kinase B (AKT) acts as a central regulatory hub in APAP-induced kidney injury.
  • Targeting AKT signaling represents a promising therapeutic strategy for mitigating acetaminophen nephrotoxicity.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
858
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
536
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
785
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
371